| Patient-focused drug development: a new direction for collaboration EM Perfetto, L Burke, EM Oehrlein, RS Epstein Medical care 53 (1), 9-17, 2015 | 137 | 2015 |
| The national economic burden of rare disease in the United States in 2019 G Yang, I Cintina, A Pariser, E Oehrlein, J Sullivan, A Kennedy Orphanet journal of rare diseases 17 (1), 163, 2022 | 112 | 2022 |
| Defining patient engagement in research: results of a systematic review and analysis: report of the ISPOR patient-centered special interest group RL Harrington, ML Hanna, EM Oehrlein, R Camp, R Wheeler, C Cooblall, ... Value in Health 23 (6), 677-688, 2020 | 108 | 2020 |
| Value to whom? The patient voice in the value discussion EM Perfetto, EM Oehrlein, M Boutin, S Reid, E Gascho Value in Health 20 (2), 286-291, 2017 | 89 | 2017 |
| Health preference research in Europe: a review of its use in marketing authorization, reimbursement, and pricing decisions—report of the ISPOR stated preference research … K Marsh, JA van Til, E Molsen-David, C Juhnke, N Hawken, EM Oehrlein, ... Value in health 23 (7), 831-841, 2020 | 44 | 2020 |
| National trends in ADHD diagnosis and treatment: comparison of youth and adult office-based visits EM Oehrlein, M Burcu, DJ Safer, JM Zito Psychiatric Services 67 (9), 964-969, 2016 | 41 | 2016 |
| Evaluation of healthcare interventions and big data: review of associated data issues CV Asche, B Seal, KH Kahler, EM Oehrlein, MG Baumgartner Pharmacoeconomics 35, 759-765, 2017 | 33 | 2017 |
| Patient-centered core impact sets: what they are and why we need them EM Perfetto, EM Oehrlein, TR Love, S Schoch, A Kennedy, J Bright The Patient-Patient-Centered Outcomes Research 15 (6), 619-627, 2022 | 19 | 2022 |
| Patient-Community perspectives on real-world evidence: enhancing engagement, understanding, and trust EM Oehrlein, JS Graff, J Harris, EM Perfetto The Patient-Patient-Centered Outcomes Research 12, 375-381, 2019 | 19 | 2019 |
| FDAMA Section 114: Why the renewed interest? EM Perfetto, L Burke, EM Oehrlein, M Gaballah Journal of Managed Care & Specialty Pharmacy 21 (5), 368-374, 2015 | 15 | 2015 |
| PEER-REVIEWED JOURNAL EDITORS’VIEWS ON REAL-WORLD EVIDENCE EM Oehrlein, JS Graff, EM Perfetto, CD Mullins, RW Dubois, C Anyanwu, ... International Journal of Technology Assessment in Health Care 34 (1), 111-119, 2018 | 13 | 2018 |
| Developing patient-centered real-world evidence: emerging methods recommendations from a Consensus process EM Oehrlein, S Schoch, M Burcu, JF McBeth, J Bright, CL Pashos, ... Value in Health 26 (1), 28-38, 2023 | 12 | 2023 |
| Patient-reported outcome measures in the food and drug administration pilot compendium: meeting today’s standards for patient engagement in development? EM Oehrlein, EM Perfetto, TR Love, Y Chung, P Ghafoori Value in Health 21 (8), 967-972, 2018 | 10 | 2018 |
| Increasing uptake of comparative effectiveness and patient-centered outcomes research among stakeholders: insights from conference discussion E Law, R Harrington, GC Alexander, S Saha, E Oehrlein, EM Perfetto Journal of comparative effectiveness research 7 (2), 181-191, 2018 | 9 | 2018 |
| Development of an international template to support patient submissions in Health Technology Assessments N Cook, H Livingstone, J Dickson, L Taylor, K Morgan, M Coombes, ... International Journal of Technology Assessment in Health Care 37 (1), e50, 2021 | 7 | 2021 |
| Improving access and quality of health care in the United States: Shared goals among patient advocates EM Oehrlein, J Harris, A Balch, P Furlong, E Hargis, M Woolley, E Perfetto The Patient-Patient-Centered Outcomes Research 14 (5), 687-690, 2021 | 5 | 2021 |
| M-CERSI Conference on Patient-Focused Drug Development Planning Committee EM Perfetto, EM Oehrlein Assessing meaningful patient engagement in drug development: a definition …, 2015 | 5 | 2015 |
| Enhancing patient centricity of real-world data research: an exploratory analysis using the patient experience mapping toolbox EM Oehrlein, M Burcu, S Schoch, LE Gressler Value in Health 26 (1), 10-17, 2023 | 4 | 2023 |
| Stakeholder perception of pharmaceutical value: A multicriteria decision analysis pilot case study for value assessment in the United States ND Mendola, E Oehrlein, EM Perfetto, K Westrich, RB McQueen Journal of Managed Care & Specialty Pharmacy 28 (10), 1190-1196, 2022 | 4 | 2022 |
| A blueprint to advance patient-centered core impact sets EM Perfetto, TR Love, EM Oehrlein, SC Schoch, J Bright, A Kennedy, ... Health Affairs Forefront, 2022 | 4 | 2022 |
